Senti Biosciences
Price & Volume
Stats
See more52W Range | $1.46-$10 |
Market Cap | $40.2M |
Shares Short | 278,885 |
Financials
See moreRevenue (12 Mos) | $338,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$35.7M |
Diluted EPS | -$8.52 |
News
See moreYahoo Finance • 2 days ago
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Yahoo Finance • 4 days ago
Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia
Yahoo Finance • 9 days ago
Senti Biosciences completes dose finding in AML therapy trial
About
CEO | Dr. Timothy K. Lu M.D., Ph.D. |
Address | 2 Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 34 |
